financetom
Business
financetom
/
Business
/
Café Coffee Day relists on the bourses at Rs 48.50 per share
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Café Coffee Day relists on the bourses at Rs 48.50 per share
Apr 26, 2021 4:19 AM

Shares of Coffee Day Enterprises Ltd (CDEL) got relisted on Monday at Rs 48.50 per share on National Stock Exchange (NSE) and at Rs 50.30 per share on the Bombay Stock Exchange (BSE).

Share Market Live

NSE

In August 2020, the trading in CDEL shares was suspended by the bourses for not complying with listing norms pertaining to the submission of quarterly financial results. At that time the stock price was around Rs 26.

However, nine months later, the stock has been relisted at around Rs 48.

Read here:

Coffee Day resumes trading, re-lists at Rs 48.50 per share on NSE

The exchanges had on January 13 said CDEL has not submitted the financial results for June 2019 and September 2019 quarters and/or not paid the fine amount levied for the non-compliance, as required under the listing norms of the Securities and Exchange Board of India (Sebi).

Earlier this month, CDEL reported default on the payment of interest/ repayment of the principal amount for loans including revolving facilities like cash credit from banks and financial institutions.

Watch the accompanying video of CNBC-TV18’s Mangalam Maloo has more details.

(Edited by : Ankit Gohel)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Golconda Gold's Q2 Revenue Increases QoQ
Golconda Gold's Q2 Revenue Increases QoQ
Aug 26, 2024
08:31 AM EDT, 08/26/2024 (MT Newswires) -- Golconda Gold ( GGGOF ) said Monday that its revenue increased 35% in the second quarter compared to the previous quarter. The company said it generated revenue of US$3.0 million from the sale of 1,721 payable ounces of gold at an operating cash cost of US$1,812 per payable ounce, compared to revenue of...
Cigna to remove AbbVie's Humira from some drug reimbursement lists next year
Cigna to remove AbbVie's Humira from some drug reimbursement lists next year
Aug 26, 2024
Aug 26 (Reuters) - Cigna ( CI ) said on Monday it will remove AbbVie's ( ABBV ) blockbuster rheumatoid arthritis drug Humira from some of its lists of preferred drugs for reimbursement in 2025, and recommend less pricey biosimilar versions of the medicine instead. Cigna ( CI ) said Boehringer Ingelheim's Cyltezo, Simlandi from Teva and Alvotech ( ALVO...
Bloomin' Brands Names Michael Spanos CEO
Bloomin' Brands Names Michael Spanos CEO
Aug 26, 2024
09:13 AM EDT, 08/26/2024 (MT Newswires) -- Bloomin' Brands ( BLMN ) said Monday that it has named Michael Spanos as its chief executive officer, effective Sept. 3. Spanos, most recently the chief operating officer of Delta Air Lines (DAL), succeeds David Deno, who announced his retirement on May 7. ...
NRX Pharmaceuticals Secures Non-Binding Debt Financing Agreements for Ketamine Clinics
NRX Pharmaceuticals Secures Non-Binding Debt Financing Agreements for Ketamine Clinics
Aug 26, 2024
09:02 AM EDT, 08/26/2024 (MT Newswires) -- NRX Pharmaceuticals' ( NRXP ) HOPE Therapeutics subsidiary said Monday it has signed a non-binding agreement for $30 million in debt financing for its first interventional psychiatric clinics using the drug ketamine. The company also signed a non-binding agreement for $10 million worth of financing for five existing clinics in the western US....
Copyright 2023-2026 - www.financetom.com All Rights Reserved